Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review

Head Neck. 2022 Apr;44(4):1014-1029. doi: 10.1002/hed.26995. Epub 2022 Feb 9.

Abstract

Long-term survival and recurrence patterns of squamous cell carcinoma arising from inverted papilloma (IP-SCC) have not been thoroughly investigated. Four electronic databases were searched and primary studies describing overall survival (OS), recurrence, and mean time to recurrence of patients with IP-SCC were included for review. Our search yielded 662 studies. The 28 studies selected for inclusion identified 663 patients with IP-SCC. In 596 patients with reported T classification, 439 (73.7%) were T3/T4 on presentation. Of the 650 participants with recurrence data (local, regional, and distant), 155 (23.8%) experienced a recurrence, with an aggregate mean time-to-recurrence of 24.3 months. In 565 patients with 5-year OS rates, the aggregate 5-year OS was 62%. Based on the literature to date, IP-SCC is associated with a 5-year OS rate of 62%. 23.8% of patients experienced recurrence at a mean time of 24.3 months, suggesting the need for long-term surveillance.

Keywords: inverted papilloma; recurrence; squamous cell carcinoma; survival; systematic review.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Humans
  • Nose Neoplasms* / pathology
  • Papilloma, Inverted* / pathology
  • Paranasal Sinus Neoplasms* / pathology
  • Retrospective Studies
  • Squamous Cell Carcinoma of Head and Neck